-
Marina attends patient summit for GSI
Marina Symcox, PhD represented GIST Support International at the Novartis Patient Summit held June 29 – July 1, 2007 near Frankfurt, Germany. The theme of this year’s meeting was "New Horizons in Treating Cancer." About 35 delegates representing GIST patient organizations from around the world (plus additional delegates representing CML patient groups) attended the meeting. […]
Continue reading -
GISTers meet in NYC
GISTers Meet in New York CityMichael Ting organized an informal lunch meeting of GISTers in the New York City area on Augist 11, 2007. Michael said "We had a nice showing for the NYC GISTers meeting this past Saturday. Thanks to everyone for taking the time to participate. In addition to getting to know one […]
Continue reading -
Demetri, Schaye Ride Pan Mass
Dr. George Demetri, leading clinical GIST researcher, participated as a rider in Dana Farber’s classic fundraiser, "The Pan Mass Challenge" (August 4-5, 2007). Pan Mass is a two-day 190+ mile cycling event in the hills of Massachusetts. Paul Schaye, an "ironman" who is a GIST patient treated by Dr. Demetri, challenged Demetri to make the […]
Continue reading -
GIST featured at MDA
The August 2007 MD Anderson newsletter CancerWise features two articles about gastrointestinal stromal tumor: Persistence Paves Way for GIST Recovery: the story of GISTer Ginger Sawyer, the treasurer for GIST Support International. Q&A: Targeted Gleevec Therapy for GIST: an interiew with GIST expert Jonathan Trent, MD Dr. Trent describes current treatment strategies at MD Anderson, […]
Continue reading -
World Congress on Gastrointestinal Cancer
Full Text at: http://www.worldgicancer.com/WCGI/webcast04/ses7.html
Continue reading -
Predicting Side Effects
Many patients worry about potential side effects before beginning to take imatinib (Gleevec). Martine van Glabbeke and coauthors published a paper with a math model to predict the probability of developing various side effects based on the patient’s condition prior to taking the drug. Dr. van Glabbeke has written a calculation routine for side effect […]
Continue reading -
GSI Signs Bad Nauheim Declaration
GSI Endorses Bad Nauheim Declaration for GIST Patients’ Right to Access Treatment Representatives from twenty three GIST patient advocacy organizations worldwide gathered in conference June 29 -July 1, 2007 in Bad Nauheim, Germany. They drafted and signed an international declaration to promote the access to state-of-the-art GIST treatment and care for all GIST patients, wherever […]
Continue reading -
GSI Reps Attend ASCO
Sherri Janousky and Carolyn Grobe are attending the American Society for Clinical Oncology meeting June 1-5, 2007 in Chicago. Both residents of the greater Chicago area, they are braving long train rides, sore feet, and heavy loads of handouts to get the GIST treatment news and research being presented at the huge meeting. Pictured here […]
Continue reading -
Do Not Interrupt Gleevec
A French trial investigating the results of interrupting Gleevec in metastatic GIST patients has been published (click for abstract). Results indicate imatinib treatment should not be interrupted to avoid reactivation of metastases.
Continue reading -
Free-access GIST reviews
An entire issue of the journal Clinical Colorectal Cancer devoted to GIST is available free-access online. Entitled "Emerging Trends in the Management of Gastrointestinal Stromal Tumors," this November 2006 issue is edited by Margaret von Mehren, MD. Physicians can obtain continuing medical education units by studying the five included papers. This project was funded by […]
Continue reading